DGX vs. GKOS: Quest Diagnostics vs. Glaukos Stock Comparison
How do Quest Diagnostics (DGX) and Glaukos (GKOS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Quest Diagnostics (DGX) and Glaukos (GKOS) both fall under the Health Care Equipment & Services industry group, but DGX is classified in Health Care Providers & Services while GKOS is classified in Health Care Equipment & Supplies.
| Profile Item | DGX | GKOS |
|---|---|---|
| Name | Quest Diagnostics Incorporated | Glaukos Corp. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 28.21 billion USD | 13.28 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | December 17, 1996 | June 25, 2015 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Total Return (1Y) | 45.88% | 179.91% |
| Total Return (3Y, Annualized) | 27.45% | 55.51% |
| Total Return (5Y, Annualized) | 14.84% | 35.14% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Volatility (1Y, Annualized) | 24.06% | 61.24% |
| Beta (5Y) | 0.54 | 0.68 |
| Max Drawdown (5Y) | -28.62% | -53.68% |
| Avg. Volume (3M) | 1.00M | 1.15M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Sharpe Ratio (1Y) | 1.73 | 2.87 |
| Sortino Ratio (1Y) | 3.16 | 5.93 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Quest Diagnostics (DGX) reports 15.32%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Quest Diagnostics (DGX) reports 9.54%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
Operating Margin (TTM)
Quest Diagnostics (DGX) at 15.63% operates in the top operating margin quartile, ahead of Glaukos (GKOS) at 0.39%, which runs around its industry’s norm.
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DGX | GKOS |
|---|---|---|
| ROE (TTM) | 15.32% | -22.84% |
| ROA (TTM) | 6.61% | -3.90% |
| Net Margin (TTM) | 9.54% | -24.60% |
| Operating Margin (TTM) | 15.63% | 0.39% |
| Gross Margin (TTM) | 33.18% | 81.13% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Quest Diagnostics (DGX) at 11.78% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Only one side can be read here: Quest Diagnostics (DGX) reports EPS growth of 13.78%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Revenue Growth (YoY) | 11.78% | 32.33% |
| Revenue Growth (3Y CAGR) | 3.74% | 21.51% |
| EPS Growth (YoY) | 13.78% | -- |
| EPS Growth (3Y CAGR) | 3.16% | -- |
Financial Strength
Current Ratio (MRQ)
Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while Glaukos (GKOS) at 4.57 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Glaukos (GKOS) at 0.15 keeps leverage in the lower industry quartile, while Quest Diagnostics (DGX) at 0.80 runs a more typical debt-to-equity mix.
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
Financial Strength Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Current Ratio (MRQ) | 1.70 | 4.57 |
| Debt / Equity (MRQ) | 0.80 | 0.15 |
| Net Debt / EBITDA | 2.38 | -- |
Dividends
Dividend Yield (TTM)
Glaukos (GKOS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a yield of 1.33%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Glaukos (GKOS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Quest Diagnostics (DGX) reports a payout of 25.10%, ranking against industry peers normally.
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DGX | GKOS |
|---|---|---|
| Dividend Yield (TTM) | 1.33% | 0.00% |
| Dividend Payout Ratio (TTM) | 25.10% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Quest Diagnostics (DGX) trades at 25.46 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
P/S Ratio (TTM)
Quest Diagnostics (DGX) at 2.38 prices around its industry’s typical P/S ratio, while Glaukos (GKOS) at 19.24 clears its benchmark range — GKOS looks notably rich on sales.
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Quest Diagnostics (DGX) at 3.68 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DGX | GKOS |
|---|---|---|
| P/E Ratio (TTM) | 25.46 | -- |
| P/S Ratio (TTM) | 2.38 | 19.24 |
| P/B Ratio (MRQ) | 3.68 | 18.51 |
| Free Cash Flow Yield (TTM) | 3.09% | 0.40% |